Evaluation of Quality of Care - Multi-disciplinary Risk Assessment and Management Programme for Patients With Hypertension, HA (QoC RAMP-HT)
1 other identifier
observational
2,496
1 country
1
Brief Summary
Hypertension (HT) is one of the major cause of morbidity and among the top 10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority (HA) has initiated service improvement through introducing the risk assessment and management programme (RAMP) to improve the quality of care (QOC) for HT patients in general outpatient clinics (GOPC). The evaluation on the QOC is an essential part of the programme in order to inform future policy. The Department of Family Medicine and Primary Care (FMPC) of the University of Hong Kong (HKU) has been appointed by the HA to carry out the evaluation of the QOC of the programme. The Action Learning and Audit Spiral methodologies to measure whether the target standard of care intended by the RAMP programme is achieved. Each RAMP participating clinic and hospital will be invited to complete a structured evaluation questionnaire. The data of all patients who have enrolled into the RAMP for more than one year will be included in the evaluation on the process and outcomes of care. One thousand two hundred and forty-eight age and disease matched control patients who have not been enrolled into the RAMP programme will be selected for the comparison in the outcomes of care. A hundred and thirty participants will be followed up by telephone to evaluate the effect of the programme in quality of life (QOL), patient enablement, and global rating of change in health condition at baseline and 6 months after enrolment. Data on the process of care will be retrieved from the HA medical records. Main Outcome Measures: The primary outcomes are the proportion of participants who have received the criterion process of care, and achieved the target blood pressure levels. Data Analysis: Descriptive statistics on proportions of centers or subjects meeting the QOC criteria will be calculated. The changes in the clinical and patient reported outcomes of RAMP subjects will be compared at 12, 24, 36 and 48 months will be compared by paired sample t-test. The clinical outcomes between RAMP subjects and control group will be compared by independent sample t-test or Chi-square test. Results: The QOC of the RAMP programme will be determined. Areas of deficiency and possible areas for quality enhancement will be identified. Conclusion: The results of this study will provide empirical evidence on whether the HA's RAMP programme can achieve improvement in QOC for HT patients. The information will be used to guide service planning and policy decision making.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 14, 2014
CompletedFirst Posted
Study publicly available on registry
August 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedSeptember 6, 2017
September 1, 2017
4 years
August 14, 2014
September 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The proportion of clinics that have satisfied each of the structure criteria
Final analysis will evaluate the period from August, 2012 to December, 2014.
Three years
The proportion of patients who have complied with the criterion process of care.
Final analysis will evaluate the period from August, 2012 to December, 2014.
Three years
The proportion of patients who have achieved a BP level <140/90mmHg.
Final analysis will evaluate the period from August, 2012 to December, 2014.
Three years
Secondary Outcomes (6)
LDL
Three years
BMI (Body Mass Index)
Three years
Occurrence of First Cardiovascular Complication
Three years
The change in SF-12v2 scores
Three years
PEI (Patient Enablement Index)
Three years
- +1 more secondary outcomes
Study Arms (1)
RAMP-HT and Non-RAMP-HT
Eligibility Criteria
All HT patients aged \<80, without prior history of diabetes and existing cardiovascular diseases, with suboptimal BP control (average systolic blood pressure (SBP) ≥ 140mmHg or average diastolic blood pressure (DBP) ≥ 90mmHg) who were enrolled into RAMP-HT.
You may qualify if:
- aged \<80
- Suboptimal BP control (average systolic blood pressure (SBP) ≥ 140mmHg or average diastolic blood pressure (DBP) ≥ 90mmHg)
You may not qualify if:
- Patients will be excluded if they are unable to understand or communicate in Chinese language, or refuse to give consent.
- Patients will be excluded if they had prior history of diabetes and existing cardiovascular diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Hospital Authority, Hong Kongcollaborator
Study Sites (1)
The University of Hong Kong
Hong Kong Island, Hong Kong
Related Publications (2)
Yu EY, Wan EY, Chan KH, Wong CK, Kwok RL, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary Risk Factor Assessment and Management Programme for Hypertension (RAMP-HT). BMC Fam Pract. 2015 Jun 19;16:71. doi: 10.1186/s12875-015-0291-0.
PMID: 26088560RESULTYu EYT, Wan EYF, Mak IL, Chao DVK, Ko WWK, Leung M, Li YC, Liang J, Luk W, Wong MMY, Ha TKH, Chan AKC, Fong DYT, Lam CLK. Assessment of Hypertension Complications and Health Service Use 5 Years After Implementation of a Multicomponent Intervention. JAMA Netw Open. 2023 May 1;6(5):e2315064. doi: 10.1001/jamanetworkopen.2023.15064.
PMID: 37223900DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Cindy L.K. Lam, MD
Department of Family Medicine and Primary Care, Faculty of Medicine, The University of Hong Kong
- PRINCIPAL INVESTIGATOR
Esther Y.T. Yu, MBBS
Department of Family Medicine and Primary Care, Faculty of Medicine, The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 14, 2014
First Posted
August 19, 2014
Study Start
September 1, 2012
Primary Completion
September 1, 2016
Study Completion
April 1, 2017
Last Updated
September 6, 2017
Record last verified: 2017-09